PRESS RELEASES

PRESS RELEASES

April 19, 2016
Core recurring revenue to increase 7% to 8% over first quarter 2015 The Company reiterates full-year 2016 revenue guidance of $94 million to $99 million and EBITDA guidance of $4.3 million to $6.3 million BELGRADE, Mont. , April 19, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc.